Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2021 | 03-2018 | 03-2007 | 03-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 2,132,745 | N/A | N/A | N/A |
| Other current assets | 54,250 | 0 | 0 | 0 |
| TOTAL | $2,186,995 | $N/A | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 14,749 | N/A | N/A | N/A |
| Investments And Advances | 289,541 | 0 | 0 | 0 |
| Other Non-Current Assets | 98,407 | 0 | 0 | 0 |
| TOTAL | $402,697 | $N/A | $N/A | $N/A |
| Total Assets | $2,589,692 | $N/A | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 20,550 | 0 | 0 | 0 |
| Accrued Expenses | 76,936 | N/A | N/A | N/A |
| Other current liabilities | 103,244 | N/A | N/A | N/A |
| TOTAL | $218,961 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 170,280 | N/A | N/A | N/A |
| Deferred Revenues | 5,918 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 251,936 | 0 | 0 | 0 |
| TOTAL | $331,217 | $N/A | $N/A | $N/A |
| Total Liabilities | $550,178 | $N/A | $N/A | $N/A |
| Shareholders' Equity | ||||
| Retained earnings | -1,918,462 | N/A | N/A | N/A |
| Other shareholders' equity | 143,171 | 0 | 0 | 0 |
| TOTAL | $2,039,514 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $2,589,692 | $0 | $0 | $0 |